Vincent Khoo

Active 1997–2025

87
Papers
18,240
Citations
60
h-index
85
i10-index

Citations

Citations per year for Vincent Khoo1994: 1 citations1998: 2 citations1999: 5 citations2000: 17 citations2001: 42 citations2002: 39 citations2003: 48 citations2004: 37 citations2005: 50 citations2006: 52 citations2007: 57 citations2008: 59 citations2009: 102 citations2010: 110 citations2011: 107 citations2012: 112 citations2013: 107 citations2014: 130 citations2015: 115 citations2016: 118 citations2017: 94 citations2018: 147 citations2019: 527 citations2020: 602 citations2021: 599 citations2022: 441 citations2023: 294 citations2024: 521 citations2025: 209 citations2026: 7 citations1995–1997: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,453 citing papers, 17.2% of this breakdownUnited Kingdom: 827 citing papers, 9.8% of this breakdownChina: 597 citing papers, 7% of this breakdownItaly: 512 citing papers, 6% of this breakdownGermany: 474 citing papers, 5.6% of this breakdownCanada: 424 citing papers, 5% of this breakdownFrance: 399 citing papers, 4.7% of this breakdownNetherlands: 369 citing papers, 4.4% of this breakdownAustralia: 312 citing papers, 3.7% of this breakdownSpain: 266 citing papers, 3.1% of this breakdownSwitzerland: 206 citing papers, 2.4% of this breakdownBelgium: 200 citing papers, 2.4% of this breakdown
0%17.2%Other 28.7%

Fields

  • Medicine69.8%
  • Biochemistry, Genetics and Molecular Biology14.8%
  • Physics and Astronomy9.3%
  • Computer Science1.8%
  • Immunology and Microbiology1.3%
  • Engineering1%
  • Other2%

Topics

  • Prostate Cancer Diagnosis and Treatment8.7%
  • Advanced Radiotherapy Techniques7.5%
  • Prostate Cancer Treatment and Research7.4%
  • Renal cell carcinoma treatment3.9%
  • Hepatocellular Carcinoma Treatment and Prognosis3.2%
  • Bladder and Urothelial Cancer Treatments1.9%
  • Other67.4%

Coauthors

All papers

Open in search
  1. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , , - Annals of Oncology 2014 cited by 2,259

  2. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , , , - Annals of Oncology 2019 cited by 1,159

  3. Baseline Cardiovascular Risk Assessment in Cancer Patients Scheduled to Receive Cardiotoxic Cancer Therapies: A Position Statement and New Risk Assessment Tools from the Cardio-Oncology Study Group of the Heart Failure Association of the European Society of Cardiology in Collaboration with the International Cardio-Oncology Society

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Hadi Skouri, Thomas Suter, Daniela Cardinale, Ronald Witteles, Michael G. Fradley, Joerg Herrmann, Robert F. Cornell, Ashutosh Wechelaker, Michael J. Mauro, Dragana Milojković, Hugues de Lavallade, Frank Ruschitzka, Andrew J.S. Coats, Petar Seferović, Ovidiu Chioncel, Thomas Thum, Johann Bauersachs, María Sol Andrés, David J. Wright, Teresa López‐Fernández, Chris Plummer, Daniel J. Lenihan - European Journal of Heart Failure 2020 cited by 770

  4. Conventional versus hypofractionated high-dose intensity-modulated radiotherapy for prostate cancer: 5-year outcomes of the randomised, non-inferiority, phase 3 CHHiP trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2016 cited by 1,317

  5. Efficacy and Safety of Autologous Dendritic Cell–Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Celestia S. Higano, Matti Aapro, Michael Krainer, Stephan Hruby, Johannes Meran, S. Polyakov, Jean‐Pascal Machiels, Thierry Roumeguère, Koen Ackaert, Nicolaas Lumen, Thierry Gil, Velko Minchev, Antoaneta Tomova, Borislav D. Dimitrov, Marchela Koleva, Antonio Juretić, Ana Fröbe, Željko Vojnović, Martin Drabek, L. Jarolím, Tomáš Büchler, Eva Kindlová, Jan Schraml, Milada Zemanová, Prausova Jana, Bohuslav Melichar, Martina Chodacká, Jan Jansa, Gedske Daugaard, Nicolas Delonchamps, Brigitte Duclos, Stéphane Culine, G. Deplanque, Sylvestre Le Moulec, Peter Hammerer, Gerald Rodemer, Manuel Ritter, Axel S. Merseburger, Marc‐Oliver Grimm, Ilija Damjanoski, Manfred Wirth, Martin Burmester, Kurt Miller, Jan Herden, Bastian Keck, Christian Wuelfing, Alexander Winter, Martin Boegemann, Ingo Kausch von Schmeling, Paolo Fornara, E. Jaeger, G. Bodoky, Zsuzsanna Pápai, Géza Böszörményi-Nagy, Paola Vanella, Héctor Soto Parrà, Rodolfo Passalacqua, Francesco Ferraù, Michele Maio, Lucia Fratino, Enrico Cortesi, Gunta Purkalne, Jolita Asadauskienė, Rasa Jančiauskienė, Skaistė Tulytė, Alvydas Česas, Marco B. Polée, Brigitte C.M. Haberkorn, Fons van de Eertwegh, Pieter van den Berg and 83 more - JAMA Oncology 2022 cited by 90

  6. ESTRO ACROP consensus guideline on CT- and MRI-based target volume delineation for primary radiation therapy of localized prostate cancer

    Authors: , , , , , , , , , , - Radiotherapy and Oncology 2018 cited by 243

  7. Pan-AKT Inhibitor Capivasertib With Docetaxel and Prednisolone in Metastatic Castration-Resistant Prostate Cancer: A Randomized, Placebo-Controlled Phase II Trial (ProCAID)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2020 cited by 81

  8. Sequencing of prostate cancers identifies new cancer genes, routes of progression and drug targets

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Sandra E. Edwards, Lucy Matthews, Valeria Bo, Daniel Leongamornlert, Stuart McLaren, Chi‐Fai Ng, Yongwei Yu, Hongwei Zhang, Tokhir Dadaev, Sarah Thomas, Douglas F. Easton, Mahbubl Ahmed, Elizabeth Bancroft, Cyril Fisher, Naomi Livni, David Nicol, Simon Tavaré, Pelvender Gill, Christopher Greenman, Vincent Khoo, Nicholas van As, Pardeep Kumar, Christopher Ogden, Declan Cahill, Alan Thompson, Erik Mayer, Edward Rowe, Tim Dudderidge, Vincent J. Gnanapragasam, Nimish Shah, Keiran Raine, David Jones, Andrew Menzies, Lucy Stebbings, Jon W. Teague, Steven Hazell, Cathy Corbishley, Johann S. de Bono, Gerhardt Attard, William B. Isaacs, Tapio Visakorpi, Michael Fraser, Paul C. Boutros, Robert G. Bristow, Paul Workman, Chris Sander, Freddie C. Hamdy, P. Andrew Futreal, Ultan McDermott, Bissan Al‐Lazikani, Andy G. Lynch, G. Steven Bova, Christopher S. Foster, Daniel S. Brewer, David E. Neal, Colin S. Cooper, Rosalind A. Eeles - Nature Genetics 2018 cited by 238

  9. Overall Survival Update for Patients with Metastatic Castration-resistant Prostate Cancer Treated with Capivasertib and Docetaxel in the Phase 2 ProCAID Clinical Trial

    Authors: , , , , , , , , , , , , - European Urology 2022 cited by 44

  10. EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer—An International Collaborative Multistakeholder Effort†

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ananya Choudhury, Éva Compérat, Simon J. Crabb, Stéphane Culine, Berardino De Bari, Willem de Blok, Pieter De Visschere, Karel Decaestecker, Konstantinos Dimitropoulos, José L. Domínguez-Escrig, Stefano Fanti, Valérie Fonteyne, Mark Frydenberg, Jurgen J. Fütterer, Georgios Gakis, Bogdan Geavlete, Paolo Gontero, Bernhard Grubmüller, S. Hafeez, Donna E. Hansel, Arndt Hartmann, Dickon Hayne, Ann Henry, Virginia Hernández, Harry W. Herr, Ken Herrmann, Peter Hoskin, J. Huguet, Barbara Alicja Jereczek‐Fossa, Rob Jones, Ashish M. Kamat, Vincent Khoo, Anne E. Kiltie, S. Krege, Sylvain Ladoire, Pedro C. Lara, Anna M. Leliveld, Estefanía Linares-Espinós, Vibeke Løgager, Anja Lorch, Yohann Loriot, Richard P. Meijer, Maria Carmen Mir, Marco Moschini, Hugh Mostafid, Arndt‐Christian Müller, Christoph R. Müller, James N’Dow, Andrea Necchi, Y. Neuzillet, Jorg R. Oddens, Jan Oldenburg, Susanne Osanto, Wim J.G. Oyen, Luís Pacheco‐Figueiredo, Helle Pappot, Manish I. Patel, Bradley R. Pieters, Karin Plass, Mesut Remzi, Margitta Retz, Jonathan Richenberg, Michael Rink, Florian Roghmann, Jonathan E. Rosenberg, Morgan Rouprêt, Olivier Rouvière, Carl Salembier, Antti Salminen, Paul Sargos and 21 more - European Urology 2019 cited by 192

  11. Stereotactic body radiotherapy for oligometastases

    Authors: , , , , , , , , , - The Lancet Oncology 2012 cited by 529

  12. Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , - The Lancet Oncology 2014 cited by 462

  13. UK Consensus on Normal Tissue Dose Constraints for Stereotactic Radiotherapy

    Authors: , , , , , , , , , , , , , , , , , - Clinical Oncology 2017 cited by 274

  14. Magnetic resonance imaging (MRI): considerations and applications in radiotherapy treatment planning

    Authors: , , , , , - Radiotherapy and Oncology 1997 cited by 321

  15. Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rakesh Raman, Kathryn Tarver, Alison Tree, Jane Worlding, James Wylie, Anjali Zarkar, Wendy R. Parulekar, Mahesh Parmar, Matthew R. Sydes, Claire Amos, Katherine E. Beaney, Katharine Bellenger, Chris Brawley, Christina Chung, Adrian Cook, Andrew Embleton-Thirsk, Silvia Forcat, Cindy Goldstein, Jenna Grabey, Dominic Hague, Anna Herasimtschuk, Zaheer Islam, Gordana Jovic, C. Maniatis, Lindsey Masters, Fatima Mohamed, Rachel C. Morgan, Claire Murphy, Dipa Noor, Max Parmar, Paul R. Patterson, Holly Pickering, Cheryl Pugh, Mary Rauchenberger, Helena Ribeiro, Carol Roach, Fatimah Seray-Wurie, Preetha Shaji, Hannah Sims, Ben Spittle, Matthew R. Sydes, Nancy Tappenden, Lilian Tsang, Barbara Uscinska, Teddy Brown, Sue Casey, Cathy N. Davidson, Conor Dellar, Mandy Fletcher, Ralph M. Meyer, Karen Murphy, Wendy R. Parulekar, Harriet Richardson, K. Martin Richardson, Kate Whelan, Donald Bissett, Shelagh Bonner-Shand, Judith Grant, Rory Lynch, Graham Macdonald, Marie McWilliam, Rachel Moir, Sue Rodwell, Kirsty Shearer, Margaret Smith, Louise Binns, Maxine Briggs, Simon Brown, Nathalie Casanova, Katy M. Clark and 2,443 more - The Lancet 2024 cited by 49

  16. Thromboxane biosynthesis in cancer patients and its inhibition by aspirin: a sub-study of the Add-Aspirin trial

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ann O’Callaghan, Andrew Eichholz, M. Kagzi, Daniel Patterson, Krishna Narahari, Jennifer Bradbury, Zuzana Stokes, Azhar Rizvi, G.A. Walker, Victoria Kunene, Narayanan Srihari, Aleksandra Gentry‐Maharaj, Angela Meade, Carlo Patrono, Bianca Rocca, Ruth E. Langley - British Journal of Cancer 2023 cited by 30

  17. Radiotherapy for renal-cell carcinoma

    Authors: , , , , , , , , , , , - The Lancet Oncology 2014 cited by 283

  18. 10-Year efficacy and co-morbidity outcomes of a phase III randomised trial of conventional vs. hypofractionated high dose intensity modulated radiotherapy for prostate cancer (CHHiP; CRUK/06/016).

    Authors: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 cited by 26

  19. A prospective prostate cancer screening programme for men with pathogenic variants in mismatch repair genes (IMPACT): initial results from an international prospective study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Julian Barwell, Manuel R. Teixeira, Louise Izatt, Mohnish Suri, Finlay Macrae, Nicola Poplawski, Rakefet Chen‐Shtoyerman, Munaza Ahmed, Hannah Musgrave, Nicola Nicolai, Lynn Greenhalgh, Carole Brewer, Nicholas Pachter, Allan D. Spigelman, Ashraf Azzabi, Brian T. Helfand, Dorothy Halliday, Saundra S. Buys, Teresa Ramón y Cajal, Alan Donaldson, Kathleen A. Cooney, Marion Harris, John McGrath, Rosemarie Davidson, Amy Taylor, Peter Cooke, Kathryn Myhill, Matthew Hogben, Neil K. Aaronson, Audrey Ardern‐Jones, Chris H. Bangma, Elena Castro, David P. Dearnaley, Alexander Dias, Tim Dudderidge, Diana M Eccles, Kate Green, Jórunn E. Eyfjörd, Alison Falconer, Christopher S. Foster, Henrik Grönberg, Freddie C. Hamdy, Oskar T. Johannsson, Vincent Khoo, Hans Lilja, Geoffrey J. Lindeman, Jan Lubiński, Karol Axcrona, Christos Mikropoulos, Anita Mitra, Clare Moynihan, Holly Ní Raghallaigh, Gad Rennert, Rebecca Collier, Lisa K. Adams, Julian Adlard, Rosa Alfonso, Saira Ali, Angela Andrew, Luís Araújo, Nazya Azam, Darran Ball, Queenstone Barker, Alon Basevitch, Barbara Benton, Cheryl Berlin, Nicola Bermingham, Leah H. Biller, Angela Bloss, Matilda Bradford and 218 more - The Lancet Oncology 2021 cited by 93

  20. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

    Authors: , , , , , , , - Annals of Oncology 2016 cited by 514

  21. Comparison of radiation side-effects of conformal and conventional radiotherapy in prostate cancer: a randomised trial

    Authors: , , , , , , , - The Lancet 1999 cited by 740

  22. New developments in MRI for target volume delineation in radiotherapy

    Authors: , - British Journal of Radiology 2006 cited by 206

  23. Impact of Hypofractionated Radiotherapy on Patient-reported Outcomes in Prostate Cancer: Results up to 5 yr in the CHHiP trial (CRUK/06/016)

    Authors: , , , , , , , , , , , , , , , , , , , - European Urology Oncology 2021 cited by 40

  24. Tumor downstaging and sphincter preservation with preoperative chemoradiation in locally advanced rectal cancer: the M. D. Anderson Cancer Center experience

    Authors: , , , , , , , , , , , - International Journal of Radiation Oncology*Biology*Physics 1999 cited by 468